https://doi.org/10.4081/pjm.2023.342

Prevalence of positive “Pap” smears and psychological experience among post-natal women in a tertiary health center in Kano, Nigeria

Vol. 6 No. 2 (2023)
Submitted: 20 May 2023
Accepted: 11 September 2023
Published: 27 December 2023
pap smear, post-partum, Kano
Abstract Views: 48
PDF: 44
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Cervical cancer is a preventable and curable disease if diagnosed early, as it has a well-evaluated natural history. Cervical screening has been associated with a 74% reduction in the incidence of cervical cancer. The study aimed to evaluate the prevalence of abnormal “Pap tests” in post-natal patients and the psychological experience of patients undergoing “Pap tests”. This was a cross-sectional study. All newly registered post-natal patients who are sexually active and at least 3 years after sexual debut, from the age of 18 years and up to 49 years, and who gave consent were recruited for the study. One hundred and fifty-four (154) women, who completed six weeks post-partum, were recruited from October 1 to November 1, 2019. The majority of the patients were in the age group of 29-39 years, 75 (48.7%). The age ranged between 18 and 49 years, with a mean age of 34.24 years ± 6.957 SD. The mean age of marriage was 19.99 years ± 5.287 SD. The age of coitarche was 10-35 years, and 105 participants (68.18%) had their first sexual contact before the age of 20 years. The “pap” smear results were positive in 3 (1.95%) patients: Low-Grade Squamous Intraepithelial Lesion (LSIL) was found in 2 (1.30%), and High-Grade Squamous Intraepithelial Lesion (HSIL) in 1 (0.65%) patient. The prevalence of positive pap smears in post-natal patients was 1.9%. The majority of women were anxious, 78 (50.65%), and depressed, 88 (57.14%), prior to evaluation. However, no statistical association was found between risk factors, anxiety, and the number of positive smears in our sample group. A statistically significant difference was observed between anxiety and “Pap-test” by age, parity, and a statistically significant association by source of awareness in this study. Anxiety is the common reaction to any procedure, investigation or delivery of results. An abnormal response needs additional support, counseling, follow-up, and a clear explanation of the plan of management. Patients with high anxiety scores will benefit from multidisciplinary management.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Johnson CY, Sharp L, Cotton SC, et al. Human Papillomavirus Infection and Anxiety: Analyses in Women with Low-Grade Cervical Cytological Abnormalities Unaware of Their Infection Status. PLoS ONE. 2011;6:e21046. DOI: https://doi.org/10.1371/journal.pone.0021046
Olumide AA, Oluwatosin OO, John OS, Francis AO. Impact of health education intervention on 1knowledge and perception of cervical cancer and cervical screening uptake among adult women in rural communities in Nigeria. BMC Public Healh. 2014; 14: 814.Parham GP. Comparison of cell collection and direct visualization cervical screening adjuncts. Am J Obstet Gynaecol. 2003;188:S13-20. DOI: https://doi.org/10.1186/1471-2458-14-814
Nwozor CM, Oragudosi AL. Awareness and Uptake of Cervical Cancer Screening among Women in Onitsha, south-East Nigeria. Green J Med Sciences. 2013;3:283-8. DOI: https://doi.org/10.15580/GJMS.2013.8.280913864
World Health Organization (WHO). WHO Guidelines for Screening and Treatment of Cervical Precancer Lesions for Cervical Cancer Prevention. 2021. Available from: https://www.who.int/publications-detail-redirect/9789240030824.
American College of Obstetricians and Gynecologists. Updated guidelines for management of cervical cancer screening abnormalities. Practice Advisory. Washington, DC: American College of Obstetricians and Gynecologists; 2020. Available at: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/10/updated-guidelines-for-management-of-cervical-cancer-screening-abnormalities.
Oluwarotimi IA, Christopher OA, Oliver CE, Olusola BF. Society of obstetrics and gynecology of Nigeria-Clinical practice. Guidelines: Guidelines for prevention of cervical cancer. TJOG. 2018;35:371-6. DOI: https://doi.org/10.4103/TJOG.TJOG_88_18
Girianelli VR, Thuler LC, Azevedo EG. Predictive capability of HPV and pap test in screening for cervical cancer over a Three-year follow up. Rev Bras Gynaecol Obstet. 2016;38:147-53. DOI: https://doi.org/10.1055/s-0036-1580712
Nadia D, Imran OM, Babatunde A, Isaac FA. Modeling optimal cervical cancer prevention strategies in Nigeria. BMC Cancer. 2014;14:365-88. DOI: https://doi.org/10.1186/1471-2407-14-365
Cull A, Cowie VJ, Farquharson DIM, et al. Early stage cervical cancer: psychosocial and sexual outcomes of treatment. Br J Cancer. 1993;68:1216-20. DOI: https://doi.org/10.1038/bjc.1993.507
Markus Z, Heide G, Michael H, Andreas H. Pessimism Predicts Anxiety, Depression and Quality of life in Female Cancer Patients. Jpn J Clin Oncol. 2010;41:87-94. DOI: https://doi.org/10.1093/jjco/hyq168
Ago B, Etokidem A, Ebughe G. Prevalence of Abnormal Cervical Cytology among Postnatal Clinic Attendees at the University of Calabar Teaching Hospital, Nigeria. Open Access Library Journal. 2016;3:1-14. DOI: https://doi.org/10.4236/oalib.1102992
Bakari F, Abdul MA, Ahmed SA. The prevalence and course of preinvasive cervical lesion during pregnancy in a Northern Nigeria teaching hospital. Ann Afr Med. 2017;16:74-80 DOI: https://doi.org/10.4103/aam.aam_35_16
Grema BA, Mafala MB, Aliyu I, Michael GC. Premalignant lesions of uterine cervix in Nigerians resident in Jos attending General out-patients and family planning clinics. NFMJ. 2018;1.
Monsonego J, Cortes J, da Silva DP, et al. Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries. BMC Women's Health 2011;11:18. DOI: https://doi.org/10.1186/1472-6874-11-18
Wei L, Weikang H, Chaofan M, et al. Pre-procedural anxiety and Associated factors Among Women seeking for Cervical Cancer Screening services in Shenzhen, China: Does past Screening Experience Matter? Front. Oncol. 2022;12:857138. DOI: https://doi.org/10.3389/fonc.2022.857138
Shehu S, Faisal SD, Muktar G. Validation of Hospital Anxiety and Depression scale among HIV/AIDS Patients in Aminu Kano Teaching Hospital, Kano, North-Western Nigeria. J of Therapy and Management in HIV infection. 2014;2:45-9.
Mufutau AY, Ayodele O. Ethnic density and prevalence of psychiatric morbidity among patients with HIV infection in Sokoto, Nigeria - A control study. Open Journal of Psychiatry. 2012;2:292-300. DOI: https://doi.org/10.4236/ojpsych.2012.24041

How to Cite

Adamou, Natalia, Usman Aliyu Umar, and Zainad Datti Ahmed. 2023. “Prevalence of Positive ‘Pap’ Smears and Psychological Experience Among Post-Natal Women in a Tertiary Health Center in Kano, Nigeria”. Pyramid Journal of Medicine 6 (2). https://doi.org/10.4081/pjm.2023.342.
Copyright (c) 2023 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.